Wednesday, 27 April 2016

Prosthetic Heart Valves Market Analysis 2007- 2021 United Kingdom

Summary
GlobalData’s new report, "United Kingdom Prosthetic Heart Valves Market Outlook to 2021", provides key market data on the United Kingdom Prosthetic Heart Valves market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves.The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.


The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope
- Market size for Prosthetic Heart Valves market segments - Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves. 
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. 
- 2014 company shares and distribution shares data for Prosthetic Heart Valves market. 
- Global corporate-level profiles of key companies operating within the United Kingdom Prosthetic Heart Valves market. 
- Key players covered include Edwards Lifesciences Corporation, Medtronic plc, St. Jude Medical, Inc. and Others.
Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future. 
- Develop market-entry and market expansion strategies. 
- Design competition strategies by identifying who-stands-where in the market. 
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. 
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Table of Contents 
1 Table of Contents 2 
    1.1 List of Tables 4 
    1.2 List of Figures 5 
2 Introduction 6 
    2.1 What Is This Report About? 6 
    2.2 Prosthetic Heart Valves Market Segmentation 6 
    2.3 Definitions of Markets Covered in the Report 7 

3 Prosthetic Heart Valves Market, United Kingdom 8 
    3.1 Prosthetic Heart Valves Market, United Kingdom, Revenue ($m), 2007-2014 8 
    3.2 Prosthetic Heart Valves Market, United Kingdom, Revenue ($m), 2014-2021 10 
      3.2.1 Mechanical Heart Valves Market, United Kingdom, Revenue ($m), by Segment, 2007-2014 12 
      3.2.2 Tissue Heart Valves Market, United Kingdom, Revenue ($m), by Segment, 2007-2014 14 
      3.2.3 Transcatheter Heart Valves Market, United Kingdom, Revenue ($m), by Segment, 2007-2014 16 
      3.2.4 Mechanical Heart Valves Market, United Kingdom, Revenue ($m), by Segment, 2014-2021 17 
      3.2.5 Tissue Heart Valves Market, United Kingdom, Revenue ($m), by Segment, 2014-2021 19 
      3.2.6 Transcatheter Heart Valves Market, United Kingdom, Revenue ($m), by Segment, 2014-2021 21 
    3.3 Prosthetic Heart Valves Market, United Kingdom, Volume (Units), 2007-2014 23 
    3.4 Prosthetic Heart Valves Market, United Kingdom, Volume (Units), 2014-2021 25 
      3.4.1 Mechanical Heart Valves Market, United Kingdom, Volume (Units), by Segment, 2007-2014 27 
      3.4.2 Tissue Heart Valves Market, United Kingdom, Volume (Units), by Segment, 2007-2014 29 
      3.4.3 Transcatheter Heart Valves Market, United Kingdom, Volume (Units), by Segment, 2007-2014 31 
      3.4.4 Mechanical Heart Valves Market, United Kingdom, Volume (Units), by Segment, 2014-2021 32 
      3.4.5 Tissue Heart Valves Market, United Kingdom, Volume (Units), by Segment, 2014-2021 34 
      3.4.6 Transcatheter Heart Valves Market, United Kingdom, Volume (Units), by Segment, 2014-2021 36 
    3.5 Prosthetic Heart Valves Market, United Kingdom, Average Price ($), 2007-2021 38 
    3.6 Prosthetic Heart Valves Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014 40 
    3.7 Prosthetic Heart Valves Market, United Kingdom, Company Share by Revenue ($m), 2014 41 
           
4 Overview of Key Companies in United Kingdom, Prosthetic Heart Valves Market 43 
    4.1 Edwards Lifesciences Corporation 43 
      4.1.1 Company Overview 43 
    4.2 Medtronic plc 43 
      4.2.1 Company Overview 43 
    4.3 Sorin S.p.A. (Inactive) 43 
      4.3.1 Company Overview 43 
    4.4 St. Jude Medical, Inc. 44 
      4.4.1 Company Overview 44 
    4.5 Direct Flow Medical, Inc. 44 
      4.5.1 Company Overview 44 
    4.6 Symetis AG 44 
      4.6.1 Company Overview 44 
    4.7 Boston Scientific Corporation 44 
      4.7.1 Company Overview 44 
    4.8 JenaValve Technology GmbH 45 
      4.8.1 Company Overview 45 
5 Prosthetic Heart Valves Market Pipeline Products 46 
6 Recent Developments 47 
    6.1 Corporate Communications 47 
      6.1.1 May 28, 2015: AorTech International announces Board Change 47 
    6.2 Financial Announcements 47 
      6.2.1 Aug 07, 2015: AorTech International : Audited results for year to March 31, 2015 47 
      6.2.2 Jul 28, 2015: Bio-Rad Announces U.S. FDA Pre-Market Approval for the BioPlex 2200 HIV Ag-Ab assay, a Novel Next Generation HIV Diagnostic Test 47 
      6.2.3 May 05, 2015: Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 49 
    6.3 Product News 57 
      6.3.1 May 28, 2015: Collagen Solutions announces New Patent Grant 57 
7 Appendix 59 
    7.1 Research Methodology 60 
      7.1.1 Coverage 60 
      7.1.2 Secondary Research 60 
      7.1.3 Primary Research 61 
      7.1.4 Market Modeling and Forecasting 62 
      7.1.5 Company Share Analysis 65 
      7.1.6 Distribution Share Analysis 66 
    7.2 Expert Panel 67 
    7.3 GlobalData Consulting 67 
    7.4 Contact Us 67 
    7.5 Disclaimer 67

Contact US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)





No comments:

Post a Comment